IFNA1 and dermatomyositis: Melanoma differentiation-associated protein 5 (MDA5) antibody–positive (MDA5+) patients had the highest serum IFN levels when compared with DM patients with anti–aminoacyl-tRNA synthetase antibodies or no autoantibody positivity (13).